Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering

Mounica Yanamandala, Wuqiang Zhu, Daniel J. Garry, Timothy J. Kamp, Joshua Hare, Ho wook Jun, Young sup Yoon, Nenad Bursac, Sumanth D. Prabhu, Gerald W. Dorn, Roberto Bolli, Richard N. Kitsis, Jianyi Zhang

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.

Original languageEnglish (US)
Pages (from-to)766-775
Number of pages10
JournalJournal of the American College of Cardiology
Volume70
Issue number6
DOIs
StatePublished - Aug 8 2017

Fingerprint

Tissue Engineering
Cell- and Tissue-Based Therapy
Genetic Techniques
Genetic Engineering
Stem Cell Transplantation
Cardiac Myocytes
Energy Metabolism
Dilatation
Stem Cells
Animal Models
Clinical Trials
Survival
Wounds and Injuries

Keywords

  • biocompatible materials
  • heart failure
  • myocardial infarction
  • myocardium
  • stem cells

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. / Yanamandala, Mounica; Zhu, Wuqiang; Garry, Daniel J.; Kamp, Timothy J.; Hare, Joshua; Jun, Ho wook; Yoon, Young sup; Bursac, Nenad; Prabhu, Sumanth D.; Dorn, Gerald W.; Bolli, Roberto; Kitsis, Richard N.; Zhang, Jianyi.

In: Journal of the American College of Cardiology, Vol. 70, No. 6, 08.08.2017, p. 766-775.

Research output: Contribution to journalReview article

Yanamandala, M, Zhu, W, Garry, DJ, Kamp, TJ, Hare, J, Jun, HW, Yoon, YS, Bursac, N, Prabhu, SD, Dorn, GW, Bolli, R, Kitsis, RN & Zhang, J 2017, 'Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering', Journal of the American College of Cardiology, vol. 70, no. 6, pp. 766-775. https://doi.org/10.1016/j.jacc.2017.06.012
Yanamandala, Mounica ; Zhu, Wuqiang ; Garry, Daniel J. ; Kamp, Timothy J. ; Hare, Joshua ; Jun, Ho wook ; Yoon, Young sup ; Bursac, Nenad ; Prabhu, Sumanth D. ; Dorn, Gerald W. ; Bolli, Roberto ; Kitsis, Richard N. ; Zhang, Jianyi. / Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. In: Journal of the American College of Cardiology. 2017 ; Vol. 70, No. 6. pp. 766-775.
@article{312b5a6e84c6484ba3a607aeec796f10,
title = "Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering",
abstract = "Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.",
keywords = "biocompatible materials, heart failure, myocardial infarction, myocardium, stem cells",
author = "Mounica Yanamandala and Wuqiang Zhu and Garry, {Daniel J.} and Kamp, {Timothy J.} and Joshua Hare and Jun, {Ho wook} and Yoon, {Young sup} and Nenad Bursac and Prabhu, {Sumanth D.} and Dorn, {Gerald W.} and Roberto Bolli and Kitsis, {Richard N.} and Jianyi Zhang",
year = "2017",
month = "8",
day = "8",
doi = "10.1016/j.jacc.2017.06.012",
language = "English (US)",
volume = "70",
pages = "766--775",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering

AU - Yanamandala, Mounica

AU - Zhu, Wuqiang

AU - Garry, Daniel J.

AU - Kamp, Timothy J.

AU - Hare, Joshua

AU - Jun, Ho wook

AU - Yoon, Young sup

AU - Bursac, Nenad

AU - Prabhu, Sumanth D.

AU - Dorn, Gerald W.

AU - Bolli, Roberto

AU - Kitsis, Richard N.

AU - Zhang, Jianyi

PY - 2017/8/8

Y1 - 2017/8/8

N2 - Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.

AB - Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.

KW - biocompatible materials

KW - heart failure

KW - myocardial infarction

KW - myocardium

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=85028597123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028597123&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2017.06.012

DO - 10.1016/j.jacc.2017.06.012

M3 - Review article

C2 - 28774384

AN - SCOPUS:85028597123

VL - 70

SP - 766

EP - 775

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 6

ER -